Other Clinical Trial - The Clinical Efficacy of DFPP in Patients With AAGN

Status Terminated

Clinical Trial Summary

The clinical efficacy of double filtration plasmapheresis(DFPP) in patients with antineutrophil cytoplasmic autoantibody associated glomerulonephritis(AAGN).

Clinical Trial Description

This is a single center, prospective, randomized,controlled study to compare the clinical efficacy of double filtration plasmapheresis (DFPP) combined with intravenous cyclophosphamide (IV-CTX) pulse therapy versus IV-CTX pulse therapy in patients with antineutrophil cytoplasmic autoantibody associated glomerulonephritis(AAGN). ;

Study Design

Related Conditions & MeSH terms

Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis
Vasculitis

Clinical Trial Details

NCT number	NCT02294344
Study type	Interventional
Source	Nanjing University School of Medicine
Contact
Status	Terminated
Phase	N/A
Start date	June 2014
Completion date	April 2017

View Details

See also
Status	Clinical Trial	Phase
Recruiting	`NCT06316076` - Safety and Efficacy Study of CD19-CAR-DNT Cells in Autoimmune Diseases	Phase 1
Completed	`NCT05988008` - A Study of CCX168 in Japanese and Caucasian Healthy Adult Males	Phase 1
Active, not recruiting	`NCT02198248` - Low-dose Glucocorticoid Vasculitis Induction Study	Phase 4
Completed	`NCT06004960` - A Study to Assess the Mass Balance Recovery (Absorption, Distribution, Metabolism and Excretion) of [14C]CCX168 in Healthy Participants	Phase 1
Not yet recruiting	`NCT06350110` - Fourth-gen CAR T Cells Targeting BCMA/CD19 for Refractory Systemic Lupus Erythematosus (SLE)	Phase 1/Phase 2
Withdrawn	`NCT01275287` - Targeting Complement Activation in Antineutrophil Cytoplasmic Autoantibodies (ANCA)-Vasculitis - Eculizumab	Phase 2
Not yet recruiting	`NCT04871191` - Study of Salvage Therapy to Treat Patients With Granulomatosis With Polyangiitis	Phase 2
Recruiting	`NCT05732402` - An Open-label Study of Povetacicept (ALPN-303) in Autoimmune Kidney Diseases	Phase 1/Phase 2
Not yet recruiting	`NCT06226662` - Study of NM8074 in Patients With Anti-Neutrophil Cytoplasmic Antibody (ANCA)-Associated Vasculitis (AAV)	Phase 2
Terminated	`NCT02749292` - Maintenance of ANCA Vasculitis Remission by Intermittent Rituximab Dosing	Phase 4
Withdrawn	`NCT01275274` - Retinoids in ANCA Small Vessel Vasculitis: Silencing Autoantigens	Phase 2
Completed	`NCT06004947` - A Study in Healthy Volunteers to Evaluate the Drug-Drug Interaction Potential of CCX168 With Concomitant Medications	Phase 1
Recruiting	`NCT05969522` - Stratified Therapy on Pediatric AAGN	Phase 4
Recruiting	`NCT03323476` - Maintaining or Stopping Immunosuppressive Therapy in Patients With ANCA Vasculitis and End-stage Renal Disease	Phase 3
Completed	`NCT05988021` - A Study in Healthy Volunteers to Evaluate the Pharmacokinetic Food Effect and Cardiac Safety of CCX168	Phase 1
Terminated	`NCT01934504` - Defining Immune Tolerance in ANCA-associated Vasculitis (AAV)	N/A
Recruiting	`NCT06056921` - Safety and Efficacy of CD19 Targeted CAR-T Therapy for Refractory Autoimmune Disease	Phase 1
Not yet recruiting	`NCT02180126` - Differing Levels of Positive Anti-Neutrophil Cytoplasm Antibody (ANCA) Test and Their Correlation With Vasculitis or Malignancy or Chronic Inflammation	N/A
Recruiting	`NCT06294236` - Study Evaluating SC291 in Subjects With Severe r/r B-cell Mediated Autoimmune Diseases (GLEAM)	Phase 1
Not yet recruiting	`NCT06379646` - An Clinical Study of YTS109 Cell Injection in Subjects With Recurrent/Refractory Autoimmune Disease	N/A